CASE STUDY

Accelerated Cancer Target ID by 75% with ML & Curated Data

Key Highlights

  • The company aimed to find targets for differentiation therapy for cancers including AML.
  • Data retrieval, harmonization and ML model development are time-consuming.
  • To help the company circumvent the time factor, Elucidata curated an omics data atlas and developed custom pipelines.
  • The company was able to identify two targets in 2-3 months compared to the 1-2 years that it generally takes.
Get your case study now
Please enter only business email ids.
Thank you for showing interest!

To know more about us, book a demo here.
Oops! Something went wrong while submitting the form.

All Case Studies

Case study: Accelerated Target ID using ML-Ready data on Polly

Data-Centric Cross-Species Target Discovery with Polly KG

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Polly Knowledge Graph (KG): Co-built, evidence-backed biology for target discovery & validation

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Data-Driven Capacity Modeling with Agentic AI

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Polly’s High-Throughput Spatial Metabolomics Pipeline Accelerated Data-to-Insight by 3X

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Modernizing a Legacy R&D Platform with GenAI-Driven Workflow and Reporting Automation

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Data Interoperability as a Service: 6X Faster Clinico-Genomic Data Integration & Analysis with Polly

Read More
Request Demo